Qiagen Non-GAAP EPS of $0.61 beats by $0.02, revenue of $533M beats by $7.09M

* Qiagen press release [https://seekingalpha.com/pr/20292837-qiagen-exceeds-q3-2025-outlook-raises-fy-2025-adj-eps-target-announces-parse-acquisition-and] (QGEN [https://seekingalpha.com/symbol/QGEN]): Q3 Non-GAAP EPS of $0.61 beats by $0.02.
* Revenue of $533M (+6.2% Y/Y) beats by $7.09M.
* Core sales +6% CER (constant exchange rates) driven by QIAstat-Dx (+11% CER), QuantiFERON (+11% CER) and Sample technologies (+3% CER)
* Full-year 2025 outlook reaffirmed for net sales growth of about 4-5% CER (about 5-6% CER core sales) and raises adj. diluted EPS target to about $2.38 CER
* Shares -3%.

MORE ON QIAGEN

* Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript [https://seekingalpha.com/article/4825792-qiagen-n-v-qgen-presents-at-bank-of-america-global-healthcare-conference-2025-transcript]
* Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Transcript [https://seekingalpha.com/article/4821706-qiagen-n-v-qgen-presents-at-baird-global-healthcare-conference-2025-prepared-remarks]
* Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4821192-qiagen-n-v-qgen-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference]
* Qiagen Q3 2025 Earnings Preview [https://seekingalpha.com/news/4513114-qiagen-q3-2025-earnings-preview]
* Qiagen to raise $750M via non-U.S. offering of convertible bonds [https://seekingalpha.com/news/4489845-qiagen-to-raise-750m-via-non-us-offering-of-convertible-bonds]